Position | Company | Period |
---|---|---|
Independent Director | Senseonics Holdings Inc | Dec. 1, 2015 - June 30, 2019 |
Independent Chairman of the Board | Clovis Oncology Inc | April 20, 2009 - June 5, 2019 |
Independent Chairman of the Board | GlycoMimetics Inc | Jan. 1, 2017 - May 17, 2019 |
Chairman of the Board | GlycoMimetics Inc | None - |
Independent Chairman of the Board | Supernus Pharmaceuticals Inc | Jan. 1, 2005 - Aug. 10, 2016 |
Director | Zosano Pharma Corp | April 1, 2012 - Jan. 22, 2016 |
Independent Director | Amicus Therapeutics Inc | Aug. 1, 2009 - March 1, 2015 |
Independent Director | Catalyst Biosciences Inc | Nov. 1, 2002 - May 31, 2013 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2018-05-11 | 2018-05-10 |
GlycoMimetics Inc
(GLYC)
|
S Sale |
5,533
-0.1%
17.8198,543 USD |
5,533 -0.1% | 17.81 | 98,543 USD | |
2018-05-11 | 2018-05-10 |
GlycoMimetics Inc
(GLYC)
|
S Sale |
4,006
-0.1%
17.8171,347 USD |
4,006 -0.1% | 17.81 | 71,347 USD | |
2015-11-18 | 2015-11-16 |
GlycoMimetics Inc
(GLYC)
|
S Sale |
452
-0.0%
6.913,123 USD |
452 -0.0% | 6.91 | 3,123 USD | |
2014-01-15 | 2014-01-15 |
GlycoMimetics Inc
(GLYC)
|
B Purchase |
512,500
+14.3%
8.004,100,000 USD |
512,500 +14.3% | 8.00 | 4,100,000 USD | |
2014-01-15 | 2014-01-15 |
GlycoMimetics Inc
(GLYC)
|
B Purchase |
487,500
+12.2%
8.003,900,000 USD |
487,500 +12.2% | 8.00 | 3,900,000 USD |